General InformationJanus Henderson Biotech Innovation Fund Ltd is a publicly-traded closed-end investment fund managed by Janus Henderson Group, a major global asset manager based in Denver, Colorado with over 1,000 employees, established in 2010.
Funding & FinancialsAs a public company, the fund operates through publicly-issued shares rather than traditional venture funding rounds; Janus Henderson Group manages assets in excess of $300 billion globally.
Leadership & TeamThe fund is managed by the Janus Henderson investment team; Andrew Weiss serves as a portfolio manager for biotech-focused strategies within the firm.
Recent ActivityThe fund continues to actively manage a diversified portfolio of biotechnology and life sciences companies focused on innovation in therapeutics, diagnostics, and enabling technologies across precision medicine and immunology sectors.